Monday, Oct 26, 2026
Focus on the big picture

CureVac CEO on IPO Pricing, Covid-19 Vaccine, Partners

Bloomberg, 15 Aug 2020
Aug.14 -- CureVac Chief Executive Officer at Franz-Werner Haas discusses the company's $213 million initial public offering, partnerships on Covid-19 vaccine ...
Related Articles